Clinical Trials List
2024-09-30 - 2028-11-30
Phase III
Recruiting8
ICD-10N05.9
Unspecified nephritic syndrome with unspecified morphologic changes
ICD-9583.0
Nephritis and nephropathy, not specified as acute or chronic, with lesion of proliferative glomerulonephritis
-
-
Trial Applicant
GEORGE CLINICAL ASIA PACIFIC LIMITED
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/13
Investigators and Locations
Co-Principal Investigator
- Mei-Yi Wu Division of Nephrology
- Chia-Te Liao Division of Nephrology
- I-WEN WU Division of Nephrology
- 林冠宏 Division of Nephrology
- Li-Yee Hong Division of Nephrology
- Cai-Mei Zheng Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- CHENG-HSU CHEN Division of Nephrology
- TUNG-MIN YU Division of Nephrology
- 蔡尚峰 Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yen-Chung Lin Division of Nephrology
- Chih-Chin Kao Division of Nephrology
- Te-Chao Fang Division of Nephrology
- Hsi-Hsien Chen Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- YU-HSIANG CHOU Division of Nephrology
- 黃道民 Division of Nephrology
- SHUEI-LIONG LIN Division of Nephrology
- 楊紹佑 Division of Nephrology
- FAN-CHI CHANG Division of Nephrology
- - - Division of Nephrology
- 陳怡婷 Division of Nephrology
- CHUN-FU LAI Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
18 participants
-
Global
598 participants
